Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review
National and international guidelines have been published recommending the use of
natriuretic peptides as an aid to the diagnosis of heart failure (HF) in acute settings; …
natriuretic peptides as an aid to the diagnosis of heart failure (HF) in acute settings; …
[HTML][HTML] Heart failure in nursing homes: A scoping review of educational interventions for optimising care provision
J McMahon, DR Thompson, J Cameron… - International Journal of …, 2024 - Elsevier
Background Heart failure has an estimated global prevalence of 64.3 million cases, with an
average age of a person living with heart failure at 75.2 years. Approximately 20% of …
average age of a person living with heart failure at 75.2 years. Approximately 20% of …
High prevalence of undetected heart failure in long‐term care residents: findings from the Heart Failure in Care Homes (HFinCH) study
Aims Diagnosis of heart failure in older people in long‐term care is challenging because of
co‐morbidities, cognitive deficit, polypharmacy, immobility, and poor access to services. This …
co‐morbidities, cognitive deficit, polypharmacy, immobility, and poor access to services. This …
Baseline plasma NT-proBNP and clinical characteristics: results from the irbesartan in heart failure with preserved ejection fraction trial
RS Mckelvie, M Komajda, J Mcmurray, M Zile… - Journal of cardiac …, 2010 - Elsevier
BACKGROUND: N-terminal B type natriuretic peptide (NT-proBNP) is usually elevated in
heart failure (HF) patients with reduced ejection fraction (EF). Less is known about NT …
heart failure (HF) patients with reduced ejection fraction (EF). Less is known about NT …
Distribution of plasma cardiac troponin I values in healthy subjects: pathophysiological considerations
A Clerico, A Fortunato, A Ripoli, C Prontera… - Clinical chemistry and …, 2008 - degruyter.com
Background: The aim of this study was to evaluate the distribution of cardiac troponin I (cTnI)
values, measured by the ADVIA TnI-Ultra method (Siemens Medical Solutions Diagnostics …
values, measured by the ADVIA TnI-Ultra method (Siemens Medical Solutions Diagnostics …
Can brain natriuretic peptide be used to guide the management of patients with heart failure and a preserved ejection fraction? The wrong way to identify new …
M Packer - Circulation: Heart Failure, 2011 - Am Heart Assoc
Physicians make the diagnosis of heart failure when patients present with exercise
intolerance that is limited by dyspnea, fatigue, or both and that can be attributed to an …
intolerance that is limited by dyspnea, fatigue, or both and that can be attributed to an …
Clinical relevance of a raised plasma N‐terminal pro‐brain natriuretic peptide level in a population‐based cohort of nonagenarians
B Vaes, W De Ruijter, J Degryse… - Journal of the …, 2009 - Wiley Online Library
OBJECTIVES: To investigate whether plasma N‐terminal pro‐brain natriuretic peptide (NT‐
proBNP) remains a specific marker of cardiac illness in very old age and can be used to …
proBNP) remains a specific marker of cardiac illness in very old age and can be used to …
B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function
R Valle, N Aspromonte, M Feola, M Milli, C Canali… - Journal of cardiac …, 2005 - Elsevier
BACKGROUND: Half of patients with heart failure (HF) have preserved left ventricular
ejection fraction (LVEF). Neurohormonal activation characterizes the disease and …
ejection fraction (LVEF). Neurohormonal activation characterizes the disease and …
N-terminal pro–B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study
DCM Corteville, K Bibbins-Domingo… - Archives of internal …, 2007 - jamanetwork.com
Background N-terminal pro–B-type natriuretic peptide (NT-proBNP) testing is useful for
diagnosing acute decompensated heart failure. Whether NT-proBNP can be used to detect …
diagnosing acute decompensated heart failure. Whether NT-proBNP can be used to detect …
Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study
PG van Peet, AJM de Craen, J Gussekloo, W de Ruijter - Age, 2014 - Springer
In the aging society, it is important to identify very old persons at high risk of functional
decline, cardiovascular disease and mortality. However, traditional risk markers lose their …
decline, cardiovascular disease and mortality. However, traditional risk markers lose their …